Status:
ENROLLING_BY_INVITATION
The Effectiveness, Cost-effectiveness, and Budget Impact of Interventions to Improve the Delivery of Cervical Cancer Screening in Puerto Rico.
Lead Sponsor:
University of Puerto Rico Comprehensive Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cervical Cancer Screening
Eligibility:
FEMALE
25-65 years
Phase:
NA
Brief Summary
Cervical cancer incidence is increasing dramatically (2.5% per year) in Puerto Rico (PR), with increased occurrence of regional (1.7% per year) and distant (4.7% per year) stage cancer, which reflects...
Detailed Description
Aim 1. Conduct a four-arm multi-site randomized controlled trial to evaluate the effectiveness of three interventions, including patient reminders plus patient navigation and self-collection of HPV te...
Eligibility Criteria
Inclusion
- 25-65 years old
- No history of cervical cancer or hysterectomy
- Have not had a Pap test in the past 3 years or more, an HPV test in the past 5 years or more, or a combination of a Pap test and an HPV test in the past 5 or more years (co-testing).
- Must have a record at the study clinics (at least 2 previous visits).
Exclusion
- Women with no telephone contact information
- Being pregnant\*
- Living with HIV, Lupus, or Crohn's\*
- Active on immunotherapy treatment\*
- History of organ transplants\*
- Will be excluded as cervical cancer screening guidelines differ for them.
Key Trial Info
Start Date :
February 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2028
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT06943547
Start Date
February 4 2025
End Date
August 31 2028
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Puerto Rico
San Juan, PR, Puerto Rico, 00927